Insiders / Bienaime Jean Jacques

Bienaime Jean Jacques

CIK 1221590personinsider
Companies
4
First seen
Mar 11, 2026
Last activity
Jun 17, 2026

Companies

4View all →
CompanyRoleShares heldPeak heldTradesLatest
Immunome Inc. · IMNMDirector43,41543,4159—
Incyte Corp · INCYDirector24,42435,8415—
Keros Therapeutics, Inc. · KROSDirector17,59217,5926—
Ascendis Pharma A/S · ASNDDirector—9005—

All securities held

7 positions · latest reported per filing
CompanySecuritySharesAs of
Ascendis Pharma A/SOrdinary Shares900May 29, 2026
Immunome Inc.Common Stock43,415Jun 5, 2026
Immunome Inc.Director Stock Option (right to buy)Derivative9,897Jun 10, 2026
Incyte CorpCommon Stock24,424Jun 8, 2026
Incyte CorpNon Qualfied Stock Option (right to buy)Derivative6,111Jun 8, 2026
Keros Therapeutics, Inc.Common Stock17,592Jun 15, 2026
Keros Therapeutics, Inc.Stock Option (right to buy)Derivative7,433Jun 3, 2026

Activity

View all →
InsidersInstitutions
This person's insider trades (Form 4), across every company.
DateActionCompanyValueShares ΔPosition afterImpact
May 26, 2026OtherINCY
Incyte Corp
Common Stock
$1.27M-13K
-36.44%
22,782
0.01% of shares
low
May 26, 2026ExerciseINCY
Incyte Corp
Common Stock
$1.27M+15K
+71.97%
35,841
0.02% of shares
low
Jun 5, 2026SellIMNM
Immunome Inc.
Common Stock
$194.1K-10K
-23.30%
32,915
0.03% of shares
medium
Jun 5, 2026BuyIMNM
Immunome Inc.
Common Stock
$116.9K+6K
+18.23%
38,915
0.03% of shares
medium
May 15, 2026BuyIMNM
Immunome Inc.
Common Stock
$103.5K+5K
+13.02%
43,415
0.04% of shares
medium
Jun 5, 2026BuyIMNM
Immunome Inc.
Common Stock
$68.1K+4K
+8.99%
42,415
0.04% of shares
medium
May 26, 2026BuyASND
Ascendis Pharma A/S
Ordinary Shares
$47.9K+200
+100.00%
400
<0.01% of shares
low
May 26, 2026BuyASND
Ascendis Pharma A/S
Ordinary Shares
$47.2K+200
200
<0.01% of shares
low
May 29, 2026BuyASND
Ascendis Pharma A/S
Ordinary Shares
$44.8K+200
+50.00%
600
<0.01% of shares
low
May 29, 2026BuyASND
Ascendis Pharma A/S
Ordinary Shares
$44.5K+200
+33.33%
800
<0.01% of shares
low